Spinout 2023.08.30 Novo Nordisk buys CBMR biotech spinout to acquire their novel approach for treating obesity and type 2 diabetes Researchers from University of Copenhagen discovered a target that suppresses hunger, stimulates calorie burning and increases insulin sensitivity. The spinout Embark Biotech has now been acquired by Novo Nordisk
Faces of CBMR 2021.10.07 “I appreciate having a deeper understanding of how the body works.” Olivia Sveidahl Johansen is a Danish PhD student in the Gerhart-Hines Group at CBMR. She joined as a student assistant in 2015 and was recently first author on a paper in Cell.
Research in Cell 2021.05.27 Scientists turn up calorie-burning in brown fat with a unique ‘on’ switch Mice genetically engineered to overproduce the receptor GPR3 in brown fat were completely protected from metabolic disease despite being continuously fed a high caloric diet.
GRANT 2020.08.03 Zach Gerhart-Hines awarded DKK 6M Distinguished Innovator grant Zach Gerhart-Hines awarded DKK 6M Distinguished Innovator grant
